Passionate about IP! Since June 2003 the IPKat has covered copyright, patent, trade mark, designs, info-tech and confidentiality issues from a mainly UK and European perspective. Read, post comments and participate!

The team is Eleonora Rosati, Annsley Merelle Ward and Merpel. E-mail the Kats here!

The team is joined by GuestKats Söğüt Atilla, Oliver Fairhurst, Claire Gregg, Georgia Jenkins and Marcel Pemsel.

SpecialKats: Verónica Rodríguez Arguijo (TechieKat), Rose Hughes (PatKat) and Jocelyn Bosse (Book Review Editor).

InternKats: Wissam Bentazar, Simone Lorenzi and Kliment Markov.
Results for EPC 2000
Now available!: English translation of Dutch Supreme Court decision in MSD v Teva highlights UK Supreme Court's Actavis decision Now available!: English translation of Dutch Supreme Court decision in MSD v Teva highlights UK Supreme Court's Actavis decision Reviewed by Annsley Merelle Ward on Thursday, November 30, 2017 Rating: 5
Dutch Supreme Court in Merck v Teva holds that second medical use claims can be directly and indirectly infringed, no matter the type Dutch Supreme Court in Merck v Teva holds that second medical use claims can be directly and indirectly infringed, no matter the type Reviewed by Annsley Merelle Ward on Saturday, November 04, 2017 Rating: 5
Fordham 2016: Will purposive construction of Swiss-type claims save second-medical use patents? Fordham 2016: Will purposive construction of Swiss-type claims save second-medical use patents? Reviewed by Annsley Merelle Ward on Tuesday, April 05, 2016 Rating: 5
Samsung appeal against Apple establishes new jurisprudence following EPC 2000 Samsung appeal against Apple establishes new jurisprudence following EPC 2000 Reviewed by Darren Smyth on Saturday, March 15, 2014 Rating: 5
Subscribe to: Posts ( Atom )
Powered by Blogger.